Authors
Ajai Chari, MD, is an expert in hematologic oncology who cares for patients at University of California San Francisco Health.
Mark F. Pyfer, MD, is a board-certified ophthalmic surgeon at Northern Ophthalmic Associates in Jenkintown, Pennsylvania. He is also on the volunteer teaching faculty and medical staff at Wills Eye Hospital and Thomas Jefferson University. This commentary represents his own personal opinion.
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
2
A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability
3
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
4
Twice-Yearly CD19 Therapy Targets MG Root Cause: Richard Nowak, MD, MS
5


